VERIFY: Early addition of vildagliptin outperforms metformin alone, later add-on



Among a cohort of adults with recent type 2 diabetes prescribed metformin, those assigned to receive vildagliptin as an add-on therapy maintained better long-term glycemic control than those who continued on monotherapy, according to findings from the VERIFY trial presented at the European Association for the Study of Diabetes annual meeting and simultaneously published in The Lancet.
In addition, those participants who received vildagliptin earlier in treatment were more successful in maintaining HbA1c below 7% than those whose therapy was intensified with vildagliptin after metformin alone



Source link

Leave a Reply!

So glad to see you sticking around!

Want to be the first one to receive the new stuff?

Enter your email address below and we'll send you the goodies straight to your inbox.

Thank You For Subscribing!

This means the world to me!

Spamming is not included! Pinky promise.